Effexor
- Product NDC
- 21695-047
- 11-digit product format
- 216950047
- Labeler code
- 21695
- Product ID
- 21695-047_8a2302ca-5c25-4d2d-9ffe-320080934aab
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- venlafaxine hydrochloride
- Dosage form
- CAPSULE, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Rebel Distributors Corp
- Application
- NDA020699
- Marketing category
- NDA
- Marketing start
- 1997-11-01
- Marketing end
- 0000-00-00
- Substance
- VENLAFAXINE HYDROCHLORIDE
- Active strength
- 150 mg/1
- Pharmacologic classes
- Norepinephrine Uptake Inhibitors [MoA],Serotonin and Norepinephrine Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA]
- NDC exclude flag
- E
- Listing certified through
- 2017-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 21695-047-15 | EffexorXR Extended-Release | 15 in 1 BOTTLE | CAPSULE, EXTENDED RELEASE | 15 | | 1 |
| 21695-047-45 | EffexorXR Extended-Release | 45 in 1 BOTTLE | CAPSULE, EXTENDED RELEASE | 45 | | 1 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| VENLAFAXINE HYDROCHLORIDE | ACTIVE INGREDIENT | 7D7RX5A8MO | EFFEXOR XR EXTENDED-RELEASE (VENLAFAXINE HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [REBEL DISTRIBUTORS CORP] | 1 | |
| VENLAFAXINE | ACTIVE MOIETY | GRZ5RCB1QG | EFFEXOR XR EXTENDED-RELEASE (VENLAFAXINE HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [REBEL DISTRIBUTORS CORP] | 1 | |
| ETHYLCELLULOSE (100 MPA.S) | INACTIVE INGREDIENT | 47MLB0F1MV | EFFEXOR XR EXTENDED-RELEASE (VENLAFAXINE HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [REBEL DISTRIBUTORS CORP] | 1 | |
| FERRIC OXIDE RED | INACTIVE INGREDIENT | 1K09F3G675 | EFFEXOR XR EXTENDED-RELEASE (VENLAFAXINE HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [REBEL DISTRIBUTORS CORP] | 1 | |
| GELATIN | INACTIVE INGREDIENT | 2G86QN327L | EFFEXOR XR EXTENDED-RELEASE (VENLAFAXINE HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [REBEL DISTRIBUTORS CORP] | 1 | |
| HYPROMELLOSE 2910 (6 MPA.S) | INACTIVE INGREDIENT | 0WZ8WG20P6 | EFFEXOR XR EXTENDED-RELEASE (VENLAFAXINE HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [REBEL DISTRIBUTORS CORP] | 1 | |
| HYPROMELLOSES | INACTIVE INGREDIENT | 3NXW29V3WO | EFFEXOR XR EXTENDED-RELEASE (VENLAFAXINE HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [REBEL DISTRIBUTORS CORP] | 1 | |
| POWDERED CELLULOSE | INACTIVE INGREDIENT | SMD1X3XO9M | EFFEXOR XR EXTENDED-RELEASE (VENLAFAXINE HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [REBEL DISTRIBUTORS CORP] | 1 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | EFFEXOR XR EXTENDED-RELEASE (VENLAFAXINE HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [REBEL DISTRIBUTORS CORP] | 1 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 21695-047 | EFFEXOR XR EXTENDED-RELEASE (VENLAFAXINE HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [REBEL DISTRIBUTORS CORP] | 1 | Legacy NDC, 2 package rows | 20101123_8a2302ca-5c25-4d2d-9ffe-320080934aab.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Status |
|---|
| 21695-047-15 | 21695004715 | 15 in 1 BOTTLE | Historical |
| 21695-047-45 | 21695004745 | 45 in 1 BOTTLE | Historical |